MOB — Moberg Pharma AB (publ) Cashflow Statement
0.000.00%
Last trade - 00:00
- SEK858.98m
- SEK803.16m
- 21
- 33
- 89
- 43
2019 June 30th | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 6 M | 18 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 595 | 14 | -20.1 | -20.2 | -27.5 |
Depreciation | |||||
Non-Cash Items | -666 | -1.61 | 0.391 | 2.17 | 4.31 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 22 | -31.8 | 1.85 | -1.37 | -12.2 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -37.9 | -15.6 | -15.3 | -16.8 | -33.2 |
Other Investing Cash Flow Items | 1,400 | -65.9 | -41.3 | -68.1 | -124 |
Acquisition of Business | |||||
Sale of Business | |||||
Change in Net Intangibles | |||||
Cash from Investing Activities | 1,400 | -65.9 | -41.3 | -68.1 | -124 |
Financing Cash Flow Items | 0 | -837 | — | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -555 | -808 | 130 | 108 | 92.3 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 808 | -890 | 73.4 | 22.9 | -65 |